Hyderabad, March 17 (RAHNUMA): Telangana has secured a distinct place on the global map in the manufacturing of advanced diagnostic kits for drug-resistant tuberculosis (TB), said Minister for IT, Electronics & Industries Duddilla Sridhar Babu.
He noted that drug-resistant TB has emerged as a major public health challenge, as it does not respond to standard treatments. Early detection and timely intervention, he said, are critical to saving lives and preventing further spread of the disease.
The Minister launched drug-resistant TB diagnostic kits, manufactured in Genome Valley, Hyderabad, at the Assembly committee hall on Tuesday. The kits are being produced by French diagnostics major bioMérieux, marking a significant milestone in strengthening India’s TB detection and control efforts.
The launch event was attended by Marc Lamy, Consul General of France in Bengaluru; Charles Mahy, Counsellor for Health and Social Affairs at the French Embassy in India; and Alexandre Mérieux, Executive Chairman of bioMérieux. Telangana Lifesciences Director Sarvesh Singh was also present.
The Minister appreciated bioMérieux for its contribution to India’s efforts towards TB elimination, particularly in addressing drug-resistant TB.
Founded in 1963, bioMérieux is a global leader in in-vitro diagnostics, with annual revenues of around USD 4 billion (approximately ₹36,000 crore) and operations in over 160 countries. The company provides innovative diagnostic solutions across infectious diseases, cancer, and industrial microbiology.
On the occasion, the Indo-French Chamber of Commerce and Industry (IFCCI) presented a report on bilateral trade relations between India and France to Minister Sridhar Babu. The report highlights the growing role of French companies in Telangana’s development and economic growth.
